Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Rigel Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RIGL
Nasdaq
8731
https://www.rigel.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Rigel Pharmaceuticals Inc
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
- Apr 12th, 2024 12:21 pm
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Apr 10th, 2024 8:30 pm
Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
- Apr 4th, 2024 12:05 pm
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
- Mar 12th, 2024 12:05 pm
Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
- Mar 7th, 2024 6:50 pm
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 4:59 pm
Q4 2023 Rigel Pharmaceuticals Inc Earnings Call
- Mar 6th, 2024 4:53 pm
Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
- Mar 6th, 2024 3:37 pm
Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
- Mar 5th, 2024 10:10 pm
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 5th, 2024 9:01 pm
OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock?
- Feb 28th, 2024 1:27 pm
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update
- Feb 27th, 2024 1:05 pm
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
- Feb 22nd, 2024 12:50 pm
Can Rigel Pharmaceuticals (RIGL) Beat Q4 Earnings Estimates?
- Feb 19th, 2024 1:34 pm
When Will Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Become Profitable?
- Jan 15th, 2024 2:13 pm
Rigel Pharmaceuticals Provides Business Update
- Jan 8th, 2024 1:05 pm
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
- Jan 4th, 2024 1:05 pm
Here's Why You Should Bet on Rigel Pharmaceuticals (RIGL) Now
- Jan 3rd, 2024 3:51 pm
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 1:05 pm
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
- Jan 2nd, 2024 4:27 pm
Scroll